In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Canada OKs Paradigm's eye imager

This article was originally published in Clinica

Executive Summary

Canadian regulators have approved for sale Paradigm Medical Industries' fourth-generation ultrasound device for imaging conditions of the eye. The P60 Ultrasound BioMicroscope (UBM) allows practitioners to acquire and view high-resolution images of the eye's anterior segment, iris, retina, vitreous body, lens and other surrounding structures. Imaging of the anterior chamber angle is one of the principal areas studied in the detection and management of glaucoma pathologies and related surgical filtering, noted the Salt Lake City, Utah firm. Paradigm added that the UBM line is its largest generator of revenues, accounting for more than 25% of sales, and providing high gross margins.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT050977

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel